BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 20495970)

  • 41. Circulating tumor cells correlate with recurrence in stage III small-cell lung cancer after systemic chemoradiotherapy and prophylactic cranial irradiation.
    Fu L; Liu F; Fu H; Liu L; Yuan S; Gao Y; Fu Z; Yu J
    Jpn J Clin Oncol; 2014 Oct; 44(10):948-55. PubMed ID: 25135984
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Concurrent versus sequential chemotherapy and radiotherapy in limited disease small cell lung cancer: a retrospective comparative study.
    El Sharouni SY; Kal HB; Barten-Van Rijbroek A; Struikmans H; Battermann JJ; Schramel FM
    Anticancer Res; 2009 Dec; 29(12):5219-24. PubMed ID: 20044639
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CNS relapse despite prophylactic cranial irradiation (PCI) in small cell lung cancer (SCLC).
    Hoskin PJ; Yarnold JR; Smith IE; Ford HT
    Int J Radiat Oncol Biol Phys; 1986 Nov; 12(11):2025-8. PubMed ID: 3021695
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Treatment of brain metastases of small-cell lung cancer: comparing teniposide and teniposide with whole-brain radiotherapy--a phase III study of the European Organization for the Research and Treatment of Cancer Lung Cancer Cooperative Group.
    Postmus PE; Haaxma-Reiche H; Smit EF; Groen HJ; Karnicka H; Lewinski T; van Meerbeeck J; Clerico M; Gregor A; Curran D; Sahmoud T; Kirkpatrick A; Giaccone G
    J Clin Oncol; 2000 Oct; 18(19):3400-8. PubMed ID: 11013281
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cerebral metastases in extrapulmonary cell carcinoma. Implications for the use of prophylactic cranial irradiation.
    Eckert F; Gani C; Bamberg M; Müller AC
    Strahlenther Onkol; 2012 Jun; 188(6):478-82. PubMed ID: 22418588
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Assessment of cognitive function after preventive and therapeutic whole brain irradiation using neuropsychological testing].
    Penitzka S; Steinvorth S; Sehlleier S; Fuss M; Wannenmacher M; Wenz F
    Strahlenther Onkol; 2002 May; 178(5):252-8. PubMed ID: 12082684
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of prophylactic cranial irradiation timing on brain relapse rates in patients with stage IIIB non-small-cell lung carcinoma treated with two different chemoradiotherapy regimens.
    Topkan E; Parlak C; Kotek A; Yuksel O; Cengiz M; Ozsahin M; Pehlivan B
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1264-71. PubMed ID: 22172902
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Indications for prophylactic cranial irradiation in patients with small cell lung cancer].
    Szczepek B; Rowińska-Zakrzewska E
    Pneumonol Alergol Pol; 1996; 64(1-2):40-4. PubMed ID: 8630463
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prophylactic Cranial Irradiation Versus Observation in Radically Treated Stage III Non-Small-Cell Lung Cancer: A Randomized Phase III NVALT-11/DLCRG-02 Study.
    De Ruysscher D; Dingemans AC; Praag J; Belderbos J; Tissing-Tan C; Herder J; Haitjema T; Ubbels F; Lagerwaard F; El Sharouni SY; Stigt JA; Smit E; van Tinteren H; van der Noort V; Groen HJM
    J Clin Oncol; 2018 Aug; 36(23):2366-2377. PubMed ID: 29787357
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A phase III trial evaluating the combination of cisplatin, etoposide, and radiation therapy with or without tamoxifen in patients with limited-stage small cell lung cancer: Cancer and Leukemia Group B Study (9235).
    McClay EF; Bogart J; Herndon JE; Watson D; Evans L; Seagren SL; Green MR;
    Am J Clin Oncol; 2005 Feb; 28(1):81-90. PubMed ID: 15685040
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of the use of prophylactic cranial irradiation in small cell lung cancer.
    Patel S; Macdonald OK; Suntharalingam M
    Cancer; 2009 Feb; 115(4):842-50. PubMed ID: 19117355
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of Prophylactic Cranial Irradiation on Overall Survival in Metastatic Small-Cell Lung Cancer: A Propensity Score-Matched Analysis.
    Sharma S; McMillan MT; Doucette A; Cohen RB; Berman A; Levin W; Simone CB; Shabason J
    Clin Lung Cancer; 2018 May; 19(3):260-269.e3. PubMed ID: 29358031
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of Adjuvant Therapy in a Population-Based Cohort of Patients With Early-Stage Small-Cell Lung Cancer.
    Yang CF; Chan DY; Speicher PJ; Gulack BC; Wang X; Hartwig MG; Onaitis MW; Tong BC; D'Amico TA; Berry MF; Harpole DH
    J Clin Oncol; 2016 Apr; 34(10):1057-64. PubMed ID: 26786925
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Patients with limited-stage small-cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and vincristine.
    Johnson BE; Bridges JD; Sobczeck M; Gray J; Linnoila RI; Gazdar AF; Hankins L; Steinberg SM; Edison M; Frame JN; Pass H; Nesbitt J; Holden D; Mulshine JL; Glatstein E; Ihde DC
    J Clin Oncol; 1996 Mar; 14(3):806-13. PubMed ID: 8622028
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prophylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-analysis.
    Meert AP; Paesmans M; Berghmans T; Martin B; Mascaux C; Vallot F; Verdebout JM; Lafitte JJ; Sculier JP
    BMC Cancer; 2001; 1():5. PubMed ID: 11432756
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early compared with late radiotherapy in combined modality treatment for limited disease small-cell lung cancer: a London Lung Cancer Group multicenter randomized clinical trial and meta-analysis.
    Spiro SG; James LE; Rudd RM; Trask CW; Tobias JS; Snee M; Gilligan D; Murray PA; Ruiz de Elvira MC; O'Donnell KM; Gower NH; Harper PG; Hackshaw AK;
    J Clin Oncol; 2006 Aug; 24(24):3823-30. PubMed ID: 16921033
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Radiochemotherapy in small-cell lung cancer.
    Kepka L; Sprawka A; Casas F; Abdel-Wahab S; Agarwal JP; Jeremic B
    Expert Rev Anticancer Ther; 2009 Oct; 9(10):1379-87. PubMed ID: 19827997
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparative study of prophylactic cranial irradiation in patients with small cell lung cancer achieving a complete response: a long-term follow-up result.
    Ohonoshi T; Ueoka H; Kawahara S; Kiura K; Kamei H; Hiraki Y; Segawa Y; Hiraki S; Kimura I
    Lung Cancer; 1993 Oct; 10(1-2):47-54. PubMed ID: 8069603
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Patterns of brain metastasis immediately before prophylactic cranial irradiation (PCI): implications for PCI optimization in limited-stage small cell lung cancer.
    Chu X; Li S; Xia B; Chu L; Yang X; Ni J; Zou L; Li Y; Xie C; Lin J; Zhu Z
    Radiat Oncol; 2019 Sep; 14(1):171. PubMed ID: 31533763
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Factors affecting the risk of brain metastasis in small cell lung cancer with surgery: is prophylactic cranial irradiation necessary for stage I-III disease?
    Gong L; Wang QI; Zhao L; Yuan Z; Li R; Wang P
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):196-200. PubMed ID: 22818415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.